Epizyme Inc. sell Lokrim
Start price
11.12.21
/
20%
€2.63
Target price
11.12.22
-
Performance (%)
-45.63%
End price
08.12.22
-
Summary
This prediction is currently being closed. The SELL prediction by Lokrim for Epizyme Inc. is performing very well with a performance of -45.63%. Lokrim has 20% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Epizyme Inc. | - | - | - |
iShares Core DAX® | 1.937% | 1.473% | 18.596% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% |
According to Lokrim what are the pros and cons of Epizyme Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Epizyme Inc. diskutieren
Sell Epizyme Inc.
In the thread Trading Epizyme Inc.
Sell beendet
Stopped prediction by Lokrim for Epizyme Inc.
Epizyme Inc.
Start price
Target price
Perf. (%)
€13.60
08.04.20
08.04.20
-
04.11.21
04.11.21
-68.53%
05.11.21
05.11.21
Probably not worthwhile Investment
Epizyme Inc.
Start price
Target price
Perf. (%)
€19.60
26.01.20
26.01.20
-
08.04.20
08.04.20
-29.08%
08.04.20
08.04.20
Probably not worthwhile Investment